Media contact: | Investor contact: |
media-relations@its.jnj.com | investor-relations@its.jnj.com |
For immediate release
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
New Brunswick, N.J., April 2nd, 2024 - Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities Health Care Conference on Tuesday, May 14th, at the Encore Hotel, Las Vegas, Nevada. John Reed, Executive Vice President, Innovative Medicine, R&D, will represent the Company in a session scheduled at 4:40 pm (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Johnson & Johnson published this content on 14 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 May 2024 10:49:53 UTC.